Biological Activities of a Human Pluripotent Hemopoietic Colony-Stimulating Factor

  • E. Platzer
  • K. Welte
  • L. Lu
  • J. L. Gabrilove
  • Y.-P. Yung
  • C. F. Nathan
  • R. Mertelsmann
  • M. A. S. Moore
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 29)


As described elsewhere in this volume by Welte et al., a human pluripotent hemopoietic colony-stimulating factor (CSF) was purified to apparent homogeneity from media conditioned by the human bladder Carcinoma cell line, 5637. The purified material supports colony formation in vitro from human multipotential (CFUGEMM), early erythroid (BFU-E), granulocyte and monocyte (CFU-G, M) progenitor cells4. A murine CSF, Interleukin 3 or multi-CSF, with similar activities on normal mouse bone marrow [1, 2], has recently been purified [3] and genetically cloned [4]. Interleukin 3 was originally detected by its ability to induce 20-alpha-C) H-steroid dehydrogenase (20aSDH) in cultured spieen cells of nu/nu mice [5]. Later in it was discovered to have biological activities on wide range of hemopoietic cells: progenitor cells of erythrocytes, megakaryocytes, granulocytes, monocytes and eosinophils, mast cells and their precursors, and possibly lymphocytes [2, 6–8]. Since come activities of Interleukin 3 and pluripotent CSF, or Pluripoietin, on hemopoietic progenitor cells appeared similiar, we screened for additional biological effects of Pluripoietin.


Hemopoietic Cell Normal Human Bone Marrow Murine Mast Cell Hemopoietic Progenitor Cell Human Bladder Carcinoma Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nicola NA, Vadas M (1984) Hemopoietic colony-stimulating factors. Immunol Today 5: 76–81CrossRefGoogle Scholar
  2. 2.
    Watson JD, Prestidge RL (1983) Interleukin 3 and colony-stimulating factors. Immunol Today 4: 278–280CrossRefGoogle Scholar
  3. 3.
    Ihle JN, Keller J, Henderson L, Klein F, Palaszynski E (1982) Procedures for the purification of Interleukin 3 to homogeneity. J Immunol 129: 2431–2436PubMedGoogle Scholar
  4. 4.
    Fung MC, Hapel AJ, Ymer S, Cohen DR, Johnson RM, Campbell HD, Young IG (1984) Molecular cloning of c-DNA for murine interleukin 3. Nature 307: 233–237PubMedCrossRefGoogle Scholar
  5. 5.
    Ihle JN, Pepersack L, Rebar L (1981) Regulation of T cell differentiation: in vitro induction of 20-alpha-steroid dehydrogenase in splenic lymphocytes is mediated by a unique lymphokine. J Immunol 126: 2184–2189PubMedGoogle Scholar
  6. 6.
    Ihle JN, Keller J, Oroszlan S, Henderson LE, Copeland TD, Fitch F, Prystowski MB, Goldwasser E, Schräder JW, Palaszynski E, Dy M, Lebel B (1983) Biologie properties of homogeneous Interleukin 3. J Immunol 131: 282–287PubMedGoogle Scholar
  7. 7.
    Razin E, Ihle JN, Seidin D, Mencia-Huerta JM, Katz HR, Leblanc PA, Hein A, Caulfield JP, Austen KF, Stevens RL. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 132: 1479–1486Google Scholar
  8. 8.
    Palacios R, Henson G, Steinmetz M, Mc- Kearn JP (1984) Interleukin 3 supports growth of mouse pre-B-cell clones in vitro. Nature 309: 126–131PubMedCrossRefGoogle Scholar
  9. 9.
    Lu L, Broxmeyer HE, Meyers PA, More MAS, Thaler T (1983) Association of cell cycle expression of Ia-like antigenic determinants on normal human multipotential (CFU-GEMM) and erythroid ( BFU-E) progenitor cells with regulation in vitro by acidic isoferritins. Blood 61: 250–256Google Scholar
  10. 10.
    Broxmeyer HE, Moore MAS, Ralph P (1977) Cell-free granulocyte colony inhibitory activity derived from human polymorphonuclear neutrophils. Exp Hematol 5: 87–102PubMedGoogle Scholar
  11. 11.
    Platzer E, Welte K, Gabrilove JL, Lu L, Nathan CF, Mertelsmann R, Moore MAS (to be published) Biological activities of a human pluripotent colony stimulating factor on normal and leukemic cellsGoogle Scholar
  12. 12.
    Hoang T, Iscove NN, Odartchenko N (1983) Macromolecules stimulating human granulocytic colony-forming cells, precursors of these cells, and primitive erythroid progenitors: some apparent nonidentities. Blood 61: 960–966PubMedGoogle Scholar
  13. 13.
    Jacobsen N, Broxmeyer HE, Grossbard E, Moore MAS (1979) Colony-forming units in diffusion Chambers (CFU-d) and colonyforming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationship. Cell Tissue Kinet 12: 213–226PubMedGoogle Scholar
  14. 14.
    Wagemaker G, Dorssers L (1984) Properties of purified stem cell activating factor (SAF) and its use for selective multiplication of stem cells for bone marrow transplantation in mice. Exp Hematol 12: 454 (abstract 247)Google Scholar
  15. 15.
    Nathan CF, Prendergast TJ, Wiebe ME, Stanley ER, Platzer E, Remold HG, Welte K, Rubin BY, Murray HW (1984) Activation of human macrophages. J Exp Med 160: 600–605PubMedCrossRefGoogle Scholar
  16. 16.
    Djeu JY, Lanza E, Pastore S, Hapel AJ (1983) Selective growth of natural cytotoxic but not natural killer effector cells in interleukin 3. Nature 306: 788–791PubMedCrossRefGoogle Scholar
  17. 17.
    Koeffler HP (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62: 709–721PubMedGoogle Scholar
  18. 18.
    Metealf D (1980) Clonal extinetion of myelomonoeytie leukemic cells by serum from mice injected with endotoxin. Int J Cancer 25: 225–233CrossRefGoogle Scholar
  19. 19.
    Tertian G, Yung YP, Guy-Grand D, Moore MAS (1980) Long-term culture of murine mast cells. I. Description of a growth factor dependent in vitro culture technique. J Immunol 127: 788–794Google Scholar
  20. 20.
    Yung YP, Eger R, Tertian G, Moore MAS (1981) Long-term in vitro culture of murine mast cells, II. Purification of a mast cell growth factor and its dissociation from TCGF. J Immunol 12: 794–799 422Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • E. Platzer
    • 1
  • K. Welte
    • 2
  • L. Lu
    • 2
  • J. L. Gabrilove
    • 2
  • Y.-P. Yung
    • 2
  • C. F. Nathan
    • 3
  • R. Mertelsmann
    • 2
  • M. A. S. Moore
    • 2
  1. 1.Institut f. klin. ImmunologieErlangenGermany
  2. 2.Laboratory of Developmental Hematopoiesis, and Laboratory of Molecular HematologyMemorial Sloan-Kettering Cancer CenterUSA
  3. 3.Laboratory of Cellular Physiology and ImmunologyThe Rockefeller UniversityNew YorkUSA

Personalised recommendations